Also trades as: 9939.HK (HKSE) · $vol 0M
KNTPF OTC
Kintor Pharmaceutical Limited
1W: +0.0%
1M: +0.7%
3M: -29.4%
YTD: +11.8%
1Y: -6.7%
3Y: -75.8%
5Y: -80.4%
$0.24
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$5M
+0.0% ▲
Gross Profit
-$5M
+88.8% ▲
Operating Income
-$145M
+5.1% ▲
Net Income
-$155M
+85.4% ▲
EPS (Diluted)
$-0.36
+85.4% ▲
EBITDA
-$128M
+87.8% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $34M | $0 | $0 | $5M |
| YoY Growth | +0.0% | +0.0% | -100.0% | +0.0% | +0.0% |
| Cost of Revenue | $942K | $0 | $3M | $42M | $10M |
| Gross Profit | -$942K | $34M | -$3M | -$42M | -$5M |
| Gross Margin | — | 100.0% | — | — | -94.6% |
| R&D Expenses | $329M | $768K | $828M | $939M | $78M |
| SG&A Expenses | $86M | $60M | $64M | $35M | $88M |
| Operating Expenses | $505M | $874M | $143M | $1.0B | $140M |
| Operating Income | -$505M | -$840M | -$945M | -$152M | -$145M |
| Operating Margin | — | -2452.8% | — | — | -2891.4% |
| Interest Expense | $516K | $2M | $8M | $10M | $9M |
| Income Before Tax | -$508M | -$842M | -$953M | -$151M | -$155M |
| Tax Expense | $73K | $0 | $1M | -$8M | $18K |
| Net Income | -$508M | -$842M | -$954M | -$1.1B | -$155M |
| Net Margin | — | -2460.0% | — | — | -3105.8% |
| EPS (Diluted) | $-1.64 | $-2.36 | $-2.53 | $-2.47 | $-0.36 |
| EBITDA | -$396M | -$828M | -$956M | -$1.1B | -$128M |
| Shares Outstanding | 309M | 356393 | 377M | 429M | 431M |